Rufang Liao
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A modified Rim APHE criterion to improve LI-RADS diagnostic performance for primary liver malignancies.
Journal: Abdominal radiology (New York)
Published: February 26, 2026
Recurrent primary intracranial myxofibrosarcoma: a case report and review of the literature.
Journal: Frontiers in oncology
Published: November 26, 2025
Feasibility of Half-Dose Gadoxetic Acid-Enhanced Liver MRI at 5.0 T: A Prospective Intrapatient Comparison with Full-Dose 3.0 T.
Journal: Academic radiology
Published: November 02, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD.
Journal: Gut
Published: July 02, 2025
Performance Evaluation of a Custom-Designed Contrast Media Injector in a 5-Tesla MRI Environment.
Journal: Bioengineering (Basel, Switzerland)
Published: April 16, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.
Journal: The Journal of clinical investigation
Published: June 20, 2023
Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.
Journal: Frontiers in endocrinology
Published: January 05, 2022
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques.
Journal: Science translational medicine
Published: December 15, 2021
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.
Journal: Cell metabolism
Published: June 04, 2020
Thin-Section Chest CT Imaging of COVID-19 Pneumonia: A Comparison Between Patients with Mild and Severe Disease.
Journal: Radiology. Cardiothoracic imaging
Published: March 13, 2020
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.
Journal: Cell metabolism
Published: October 31, 2019
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.
Journal: Cell metabolism
Published: October 11, 2019
Last Updated: 09/26/2026